Clinical Trial Update: A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older. [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing MPR (melphalan-prednisone-thalidomide) with MP (melphalan-prednisone) in newly diagnosed multiple myeloma patients aged 65 and ol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Melphalan (Melphalan)
• PREDNISONE (Prednisone)
• Thalidomide (thalidomide)

Snippet

Sponsor: Celgene Corporation | Conditions: Newly Diagnosed Multiple Myeloma | Phase 3 | Status: COMPLETED | Results posted: 2012-05-11